Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 9,049 | 8,642 | 8,317 | 6,254 | 5,320 |
| Operating Income | -9,049 | -8,642 | -8,317 | -6,254 | -5,320 |
| Interest Expense | 0 | 0 | 0 | 480 | 0 |
| Other Income | 317 | 380 | 237 | 0 | 216 |
| Pre-tax Income | -8,732 | -8,262 | -8,080 | -6,734 | -5,104 |
| Income Tax | 21 | 10 | N/A | -544 | N/A |
| Net Income Continuous | -8,753 | -8,272 | -8,080 | -6,190 | -5,104 |
| Net Income | $-8,753 | $-8,272 | $-8,080 | $-6,190 | $-5,104 |
| EPS Basic Total Ops | -3.20 | -2.93 | -2.80 | -2.16 | -1.79 |
| EPS Basic Continuous Ops | -3.17 | -2.93 | -2.83 | -2.17 | -1.79 |
| EPS Diluted Total Ops | -3.20 | -2.93 | -2.80 | -2.16 | -1.79 |
| EPS Diluted Continuous Ops | -3.17 | -2.93 | -2.83 | -2.17 | -1.79 |
| EBITDA(a) | $-9,033 | $-8,628 | $-8,300 | $-6,240 | $-5,307 |